Overview
Pancreatic and peripancreatic necrosis represent severe complications often associated with acute pancreatitis, trauma, or pancreatic malignancies. These conditions can lead to significant morbidity and mortality due to systemic inflammatory responses, local tissue destruction, and potential for infection. The management of these entities has evolved with advancements in minimally invasive surgical techniques (MIS), although traditional open surgical approaches remain crucial in certain scenarios. Recent trends indicate an increasing adoption of MIS in hepatobiliary and pancreatic (HPB) surgeries, which may influence patient outcomes and care pathways, though the specific impact on necrosis management requires further exploration. Understanding the epidemiology, clinical presentation, and prognostic factors is essential for optimizing patient care and improving survival rates.
Epidemiology
The epidemiology of pancreatic and peripancreatic necrosis is multifaceted, influenced by both underlying pathologies and evolving surgical practices. From 2010 to 2019, there has been a notable shift towards minimally invasive surgical techniques (MIS) in the management of hepatobiliary and gastric cancers, with the proportion of hospitals performing over 50% of their cases via MIS increasing from 1% to 27% [PMID:40632432]. This trend reflects broader advancements in surgical technology and a growing preference for less invasive approaches that can potentially reduce postoperative complications and improve recovery times. However, the direct impact of these trends on the incidence and management of pancreatic and peripancreatic necrosis specifically remains an area of ongoing research. While MIS adoption in colorectal cancers (CRC) has shown a modest influence on MIS adoption for HPB/gastric cancers, including pancreatic surgeries, the primary drivers appear to be intra-specialty factors rather than cross-specialty influence from CRC surgeons [PMID:40632432]. This suggests that specialized training and expertise within HPB surgery play a critical role in the adoption of MIS techniques, which could indirectly affect the management strategies for necrosis in these patients.
Clinical Presentation
The clinical presentation of pancreatic and peripancreatic necrosis can be highly variable, often complicating early diagnosis and management. Patients typically present with severe abdominal pain, which may be localized to the upper abdomen or radiate to the back. Systemic inflammatory response syndrome (SIRS) signs, including fever, tachycardia, and leukocytosis, are common due to the intense inflammatory process. Early recognition of necrosis is crucial, and clinical evaluation should include a thorough assessment of muscle strength and nutritional status, as these factors significantly influence prognosis. Specifically, low skeletal muscle mass index (SMI) and handgrip strength (HGS) have emerged as important prognostic indicators. Studies have identified cutoff values of SMI at 7.21 kg/m2 and HGS at 28 kg for men as predictive of poorer survival outcomes in patients with gastrointestinal and hepatobiliary pancreatic cancers [PMID:36122543]. These findings underscore the importance of assessing nutritional status and muscle function in patients with pancreatic pathologies, as they can provide valuable insights into the patient's overall resilience and potential for recovery. In clinical practice, integrating these assessments into routine evaluations can help tailor more personalized treatment plans and prognostic discussions with patients.
Diagnosis
Diagnosing pancreatic and peripancreatic necrosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Clinicians typically initiate the diagnostic process with a thorough history and physical examination, focusing on signs of systemic inflammation and localized abdominal tenderness. Imaging plays a pivotal role in confirming the presence and extent of necrosis. Contrast-enhanced computed tomography (CT) scans are considered the gold standard, capable of distinguishing between different stages of necrosis (e.g., sterile, infected) and identifying complications such as pseudocysts or abscesses. Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography (MRCP) can also be valuable, particularly for assessing ductal anatomy and identifying biliary obstruction. Laboratory findings often reveal elevated inflammatory markers (e.g., C-reactive protein, white blood cell count) and may show signs of organ dysfunction, depending on the severity of the condition. While specific biomarkers for necrosis are limited, monitoring these parameters helps guide clinical decision-making and monitor disease progression. Early and accurate diagnosis is critical for timely intervention and improved patient outcomes.
Management
The management of pancreatic and peripancreatic necrosis is multifaceted, encompassing supportive care, surgical interventions, and targeted therapies to address complications such as infection and hemorrhage. Supportive care is foundational, focusing on fluid resuscitation, pain management, and nutritional support. In cases of severe necrosis, particularly when infection is suspected or confirmed, surgical intervention may be necessary. Traditional open surgical approaches, including necrosectomy, remain essential for extensive necrosis or when complications arise. However, minimally invasive techniques (MIS) have gained traction, offering potential benefits such as reduced postoperative morbidity and faster recovery times. MIS approaches include endoscopic necrosectomy and percutaneous catheter drainage, which can be effective for localized necrosis and in selected patients. The adoption of MIS in colorectal cancers (CRC) has shown a modest influence on its use in HPB surgeries, including pancreatic cases, primarily driven by intra-specialty factors rather than cross-specialty influence [PMID:40632432]. This suggests that specialized training and experience within HPB surgery are crucial for safely implementing MIS techniques. Additionally, managing complications such as infected necrosis requires aggressive antibiotic therapy tailored to culture-specific sensitivities and, in some cases, surgical debridement to remove necrotic tissue and control infection.
Supportive Care
Supportive care forms the cornerstone of managing patients with pancreatic and peripancreatic necrosis. Key components include:
Surgical Interventions
Surgical interventions are tailored based on the extent and complications of necrosis:
Antibiotic Therapy and Infection Control
Infection management is critical in preventing further tissue damage and systemic complications:
Prognosis & Follow-up
The prognosis for patients with pancreatic and peripancreatic necrosis varies widely depending on the extent of necrosis, presence of infection, and overall patient health status. Prognostic factors identified in recent studies highlight the importance of nutritional and functional status:
Follow-up Care
Effective follow-up care is essential for monitoring recovery and managing long-term sequelae:
Key Recommendations
By integrating these recommendations, clinicians can enhance patient outcomes and improve survival rates in the challenging context of pancreatic and peripancreatic necrosis.
References
1 Pannekoek A, Melamed A, Rauh-Hain JA, Ruan M, Lipsitz SR, Siguo L et al.. Cross-specialty impact in the adoption of minimally invasive surgery in abdominal surgical oncology at the hospital level. Journal of robotic surgery 2025. link 2 Nasu N, Yasui-Yamada S, Kagiya N, Takimoto M, Kurokawa Y, Tani-Suzuki Y et al.. Muscle strength is a stronger prognostic factor than muscle mass in patients with gastrointestinal and hepatobiliary pancreatic cancers. Nutrition (Burbank, Los Angeles County, Calif.) 2022. link
2 papers cited of 3 indexed.